DB17517InvestigationalProtein Based Therapies
Retlirafusp alfa: Overview.
- Mechanism
- Curator reviewed
Pharmacologically active on Transforming growth factor beta-1 proprotein, Programmed cell death 1 ligand 1, and Transforming growth factor beta-3 proprotein
- Also known as
- Immunoglobulin G4 (52-glycine, 57-phenylalanine, 227-proline, 233-alanine, 234-alanine, 446-alanine), anti-(human programmed death-ligand 1) (human-mus musculus monoclonal SHR-1316 .gamma.4-chain) fusion protein with peptide linker ((ggggs)4g) fusion protein with 20-136-type II transforming growth factor .beta. receptor (human isoform 1), disulfide with (85-glutamic acid) human-mus musculus monoclonal SHR-1316 .kappa.-chain, dimer
- Code names
- SHR -1701
Resolves to
Compound
What you can answer from here — as of July 08, 2026
Which drugs share a target with Retlirafusp alfa, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account